A court ruling requires mifepristone to be distributed only in-person at clinics, overturning FDA regulations. The decision is expected to be appealed to the U.S. Supreme Court, potentially reshaping medication access policies.
Search
Congressional trades, bills, prediction markets, hearings, and intelligence signals. Signal search supports: AND OR "exact phrase" -exclude